14-23988963-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_198083.4(DHRS4L2):āc.16C>Gā(p.Leu6Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,612,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_198083.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DHRS4L2 | NM_198083.4 | c.16C>G | p.Leu6Val | missense_variant | 1/8 | ENST00000335125.11 | NP_932349.2 | |
DHRS4L2 | NM_001193635.1 | c.45-1219C>G | intron_variant | NP_001180564.1 | ||||
DHRS4L2 | NM_001193636.1 | c.-175-1219C>G | intron_variant | NP_001180565.1 | ||||
DHRS4L2 | NM_001193637.1 | c.-175-1219C>G | intron_variant | NP_001180566.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DHRS4L2 | ENST00000335125.11 | c.16C>G | p.Leu6Val | missense_variant | 1/8 | 1 | NM_198083.4 | ENSP00000334801.6 |
Frequencies
GnomAD3 genomes AF: 0.0000593 AC: 9AN: 151866Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000803 AC: 2AN: 249196Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134840
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460226Hom.: 0 Cov.: 34 AF XY: 0.00000275 AC XY: 2AN XY: 726328
GnomAD4 genome AF: 0.0000593 AC: 9AN: 151866Hom.: 0 Cov.: 33 AF XY: 0.0000539 AC XY: 4AN XY: 74150
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.16C>G (p.L6V) alteration is located in exon 1 (coding exon 1) of the DHRS4L2 gene. This alteration results from a C to G substitution at nucleotide position 16, causing the leucine (L) at amino acid position 6 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at